Virarkar Mayur, Ganeshan Dhakshinamoorthy, Gulati Anjalie Tara, Palmquist Sarah, Iyer Revathy, Bhosale Priya
Department of Diagnostic Radiology, Unit 1476, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
BS, Anthropology and Global Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Abdom Radiol (NY). 2021 Jun;46(6):2323-2349. doi: 10.1007/s00261-020-02847-2. Epub 2020 Nov 11.
Ovarian cancer is a challenging disease. It often presents at an advanced stage with frequent recurrence despite optimal management. Accurate staging and restaging are critical for improving treatment outcomes and determining the prognosis. Imaging is an indispensable component of ovarian cancer management. Hybrid imaging modalities, including positron emission tomography/computed tomography (PET/CT) and PET/magnetic resonance imaging (MRI), are emerging as potential non-invasive imaging tools for improved management of ovarian cancer. This review article discusses the role of PET/CT and PET/MRI in ovarian cancer.
卵巢癌是一种具有挑战性的疾病。尽管进行了最佳管理，它仍常处于晚期且频繁复发。准确分期和再分期对于改善治疗结果和确定预后至关重要。影像学检查是卵巢癌管理中不可或缺的组成部分。包括正电子发射断层扫描/计算机断层扫描（PET/CT）和PET/磁共振成像（MRI）在内的混合成像模式，正逐渐成为改善卵巢癌管理的潜在非侵入性成像工具。这篇综述文章讨论了PET/CT和PET/MRI在卵巢癌中的作用。
